Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- PGF1a cPLA2i 1.0 BCD110605C16 - pmol/ml of medium
- PGF1a cPLA2i 1.0 BCD110605C18 4.58 pmol/ml of medium
- PGF1a cPLA2i 1.0 BCD110605C17 2.59 pmol/ml of medium
- PGF1a cPLA2i 4.0 BCD110605C34 3.09 pmol/ml of medium
- PGF1a cPLA2i 4.0 BCD110605C36 - pmol/ml of medium
- PGF1a cPLA2i 4.0 BCD110605C35 0.287 pmol/ml of medium
- PGF1a cPLA2i 20.0 BCD110605C53 8.89 pmol/ml of medium
- PGF1a cPLA2i 20.0 BCD110605C54 2.2 pmol/ml of medium
- PGF1a cPLA2i 20.0 BCD110605C52 7 pmol/ml of medium
- PGF1a PLDi 1.0 BCD110605C10 0.166 pmol/ml of medium
- PGF1a PLDi 1.0 BCD110605C12 - pmol/ml of medium
- PGF1a PLDi 1.0 BCD110605C11 0.227 pmol/ml of medium
- PGF1a PLDi 4.0 BCD110605C30 - pmol/ml of medium
- PGF1a PLDi 4.0 BCD110605C29 - pmol/ml of medium
- PGF1a PLDi 4.0 BCD110605C28 2.8 pmol/ml of medium
- PGF1a PLDi 20.0 BCD110605C48 7.09 pmol/ml of medium
- PGF1a PLDi 20.0 BCD110605C47 8.79 pmol/ml of medium
- PGF1a PLDi 20.0 BCD110605C46 8.69 pmol/ml of medium
- PGF1a KDO+cPLA2i 1.0 BCD110605C19 0.889 pmol/ml of medium
- PGF1a KDO+cPLA2i 1.0 BCD110605C21 - pmol/ml of medium
- PGF1a KDO+cPLA2i 1.0 BCD110605C20 1.41 pmol/ml of medium
- PGF1a KDO+cPLA2i 4.0 BCD110605C39 1.95 pmol/ml of medium
- PGF1a KDO+cPLA2i 4.0 BCD110605C37 2.48 pmol/ml of medium
- PGF1a KDO+cPLA2i 4.0 BCD110605C38 5.8 pmol/ml of medium
- PGF1a KDO+cPLA2i 20.0 BCD110605C55 25.9 pmol/ml of medium
- PGF1a KDO+cPLA2i 20.0 BCD110605C57 12.3 pmol/ml of medium
- PGF1a KDO+cPLA2i 20.0 BCD110605C56 3.58 pmol/ml of medium
- PGF1a KDO+PLDi 1.0 BCD110605C15 1.97 pmol/ml of medium
- PGF1a KDO+PLDi 1.0 BCD110605C14 - pmol/ml of medium
- PGF1a KDO+PLDi 1.0 BCD110605C13 - pmol/ml of medium
- PGF1a KDO+PLDi 4.0 BCD110605C32 - pmol/ml of medium
- PGF1a KDO+PLDi 4.0 BCD110605C31 2 pmol/ml of medium
- PGF1a KDO+PLDi 4.0 BCD110605C33 1.21 pmol/ml of medium
- PGF1a KDO+PLDi 20.0 BCD110605C49 7.05 pmol/ml of medium
- PGF1a KDO+PLDi 20.0 BCD110605C51 6.57 pmol/ml of medium
- PGF1a KDO+PLDi 20.0 BCD110605C50 20.8 pmol/ml of medium
- PGF1a KDO + ATP 1.0 BCD110605C07 0.135 pmol/ml of medium
- PGF1a KDO + ATP 1.0 BCD110605C09 2.2 pmol/ml of medium
- PGF1a KDO + ATP 1.0 BCD110605C08 1.18 pmol/ml of medium
- PGF1a KDO + ATP 4.0 BCD110605C25 2.42 pmol/ml of medium
- PGF1a KDO + ATP 4.0 BCD110605C26 - pmol/ml of medium
- PGF1a KDO + ATP 4.0 BCD110605C27 3.88 pmol/ml of medium
- PGF1a KDO + ATP 20.0 BCD110605C45 14.9 pmol/ml of medium
- PGF1a KDO + ATP 20.0 BCD110605C43 24.3 pmol/ml of medium
- PGF1a KDO + ATP 20.0 BCD110605C44 4.34 pmol/ml of medium
- PGF1a C 0.0 BCD110605C02 - pmol/ml of medium
- PGF1a C 0.0 BCD110605C01 - pmol/ml of medium
- PGF1a C 0.0 BCD110605C03 - pmol/ml of medium
- PGF1a C 1.0 BCD110605C06 - pmol/ml of medium
- PGF1a C 1.0 BCD110605C05 0.924 pmol/ml of medium